• ##navigation.register##
  • ##navigation.login##
    • en
    • uz
    • ru
  • en
  • uz
  • ru
##navigation.register## ##navigation.login##
  • Joriy
  • ##navigation.archives##
    • ##about.aboutContext##
    • ##about.submissions##
    • ##common.editorialMasthead##
    • ##manager.setup.privacyStatement##
    • ##about.contact##
Joriy ##navigation.archives##
##about.aboutContext## ##about.submissions## ##common.editorialMasthead## ##manager.setup.privacyStatement## ##about.contact##
  1. ##common.homepageNavigationLabel##
  2. ##common.search##

##common.search##

##search.advancedFilters##
##search.dateFrom##
##search.dateTo##

##search.searchResults##

##search.searchResults.foundSingle##
  • FEATURES OF HORMONAL STATUS IN WOMEN WITH BREAST FIBROADENOMA

    Azizova G.Dj., Lutpillaeva A.M.

    Objective: To investigate clinical, hormonal, and ultrasound characteristics in women with breast fibroadenoma and assess the role of endocrine disorders in its pathogenesis.
    Materials and Methods: Eighty-four women aged 18–45 years (mean 32.6 ± 6.7) with breast fibroadenoma were examined. Assessments included anamnesis, clinical and anthropometric evaluation, ultrasound of pelvic organs, breasts, thyroid gland, and hormonal profile (FSH, LH, prolactin, TSH, free T3/T4, estradiol, progesterone, free testosterone).
    Results: Menstrual disorders occurred in 60 (71.4%) patients, mainly oligomenorrhea/opsomenorrhea — 32 (53.3%) and chronic anovulation — 20 (33.3%). Infertility was present in 17 (40.4%), mean duration 4.01 ± 0.18 years. Metabolic disturbances affected 71.3% of participants. Ultrasound abnormalities included endometriosis (38%), uterine myoma (21.4%), follicular cysts (31%), and polycystic ovaries (10.8%). Hormonal disorders were dominated by thyroid hypofunction (46.7%) and hyperprolactinemia (23.8%). Estradiol and progesterone were within reference ranges in most cases.
    Conclusion: Breast fibroadenoma in reproductive-age women is associated with complex hormonal imbalance, particularly thyroid dysfunction and hyperprolactinemia, rather than isolated hyperestrogenism, underscoring the need for comprehensive endocrine evaluation and targeted management.

    72-77
    28-01-2026
    Davomini o‘qing
##navigation.items##

Ma'lumot

  • ##navigation.infoForReaders##
  • Mualliflar uchun
  • Kutubxonachilar uchun

So'nggi nashrlar

  • Atom logotipi
  • RSS2 logotipi
  • RSS1 logotipi
TNMU Publishing

Biz tibbiyotning rivojlanishini tezlashtirish va jamiyat salomatligini yaxshilash uchun tadqiqotchilar, bilim va texnologiyalarni birlashtiramiz.

 

Navigatsiya

Bosh sahifa
Jurnallar
Konferensiyalar
Mualliflar
Taqrizchilar
Nashriyot xizmatlari

Madad

Ijodkor qoidalari
Nashr axloqi
Biz haqimizda
Savol-javob
Qayta aloqa

Kontaktlar

 
O‘zbekiston, Toshkent,,
Olmazor tumani, Shifokorlar ko‘chasi, 21-uy
 
(+998) 91 164 24 40
 
publishing@tnmu.uz
© Copyright 2026 TNMU Publishing All Rights Reserved | Developed by in Science | Site create by in Designer
##user.login##
Central Asian Journal of Medicine
##user.login##
* ##common.required##
* ##common.required##
##user.login.forgotPassword##
##user.login.rememberUsernameAndPassword##
##user.login.registerNewAccount##